This guideline defines scientific principles and provides guidance for the development and evaluation of gene therapy medicinal products (GTMP) intended for use in humans and presented for marketing authorisation. Its focus is on the quality, safety and efficacy requirements of GTMPs.

 

 

Posted on the EMA website on 20 May 2015